Profile data is unavailable for this security.
About the company
Sigyn Therapeutics, Inc. (Sigyn) is a development-stage company. The Company is focused on creating therapeutic solutions that address unmet needs in global health. The Company's product candidate, Sigyn Therapy, is a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders. Its treatment indications include endotoxemia and inflammation in end-stage renal disease (dialysis) patients, sepsis (a cause of hospital deaths), community-acquired pneumonia (a cause of death among infectious diseases), and emerging pandemic threats. Sigyn Therapy is a single-use disposable device that is deployable on the global infrastructure of hemodialysis and continuous renal replacement therapy (CRRT) machines. The Company’s development pipeline includes a cancer treatment system comprised of ChemoPrep to enhance the tumor site delivery of chemotherapy, and ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis.
- Revenue in USD (TTM)0.00
- Net income in USD-3.70m
- Incorporated2014
- Employees5.00
- LocationSigyn Therapeutics Inc9190 W Olympic Blvd # 263BEVERLY HILLS 90212United StatesUSA
- Phone+1 (619) 368-2000
- Fax+1 (845) 818-3588
- Websitehttps://www.sigyntherapeutics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kelyniam Global Inc | 517.70k | -420.28k | 4.39m | 0.00 | -- | 8.11 | -- | 8.48 | -0.0253 | -0.0253 | 0.0312 | 0.0179 | 0.4135 | 7.04 | 4.38 | -- | -33.57 | -- | -41.79 | -- | 18.86 | -- | -81.18 | -- | 1.26 | -- | 0.6232 | -- | -26.47 | -- | -19.10 | -- | -- | -- |
| Encision Inc | 6.56m | -529.29k | 4.63m | 22.00 | -- | 2.49 | -- | 0.7056 | -0.045 | -0.045 | 0.556 | 0.1566 | 1.70 | 2.10 | 7.59 | 298,337.30 | -13.69 | -3.03 | -19.50 | -4.13 | 49.00 | 51.25 | -8.06 | -1.89 | 1.01 | -8.89 | 0.1761 | -- | -10.38 | -5.64 | -113.55 | -- | -9.54 | -- |
| Hawkeye Systems Inc | 0.00 | -578.72k | 4.79m | 44.00 | -- | -- | -- | -- | -0.093 | -0.093 | 0.00 | -0.3006 | 0.00 | -- | -- | -- | -117.01 | -314.04 | -- | -- | -- | -- | -- | -195.39 | -- | -1.49 | -- | -- | -- | -- | 52.81 | -- | -- | -- |
| Nu-Med Plus Inc | 0.00 | -112.13k | 4.87m | 2.00 | -- | -- | -- | -- | -0.0014 | -0.0014 | 0.00 | -0.0022 | 0.00 | -- | -- | 0.00 | -471.23 | -447.69 | -- | -- | -- | -- | -- | -- | -- | -21.34 | -- | -- | -- | -- | 3.56 | -- | -- | -- |
| Reflect Scientific Inc | 1.73m | -53.09k | 5.05m | 7.00 | -- | 2.57 | 65.62 | 2.92 | -0.0006 | -0.0006 | 0.0203 | 0.023 | 0.7197 | 0.8463 | 17.05 | 247,638.60 | -2.20 | 11.10 | -2.59 | 13.21 | 58.19 | 62.48 | -3.06 | 10.00 | 5.68 | -- | 0.00 | -- | -47.09 | -6.99 | -613.46 | -- | -- | -- |
| ADM Tronics Unlimited Inc | 3.06m | -472.80k | 5.15m | 7.00 | -- | 5.05 | -- | 1.68 | -0.007 | -0.007 | 0.0453 | 0.0151 | 1.11 | 3.72 | 5.67 | -- | -17.14 | -15.22 | -29.35 | -22.09 | 42.87 | 41.15 | -15.45 | -18.58 | 0.8954 | -- | 0.3259 | -- | -19.35 | -0.3572 | -810.74 | -- | -- | -- |
| Biomerica Inc | 5.41m | -5.98m | 5.33m | 63.00 | -- | 0.8091 | -- | 0.9851 | -0.3554 | -0.3554 | 0.3218 | 0.3918 | 0.4566 | 2.17 | 6.49 | 85,920.63 | -50.43 | -44.68 | -61.13 | -51.73 | 11.23 | 14.11 | -110.44 | -63.82 | 2.43 | -- | 0.00 | -- | 1.42 | 0.8109 | 16.27 | -- | -7.64 | -- |
| Dror Ortho-Design Inc | 0.00 | -5.63m | 5.35m | 4.00 | -- | 3.23 | -- | -- | -0.012 | -0.012 | 0.00 | 0.0034 | 0.00 | -- | -- | -- | -577.48 | -140.50 | -1,394.24 | -- | -- | -- | -- | -118,188.00 | -- | -- | 0.00 | -- | -- | -- | -1,896.02 | -- | -- | -- |
| Aethlon Medical, Inc. | 0.00 | -11.50m | 5.53m | 14.00 | -- | 0.6351 | -- | -- | -3.87 | -3.87 | 0.00 | 0.6251 | 0.00 | -- | -- | 0.00 | -84.49 | -76.25 | -98.84 | -85.78 | -- | -- | -- | -2,246.87 | -- | -- | 0.00 | -- | -100.00 | -- | -1.43 | -- | -- | -- |
| Biotricity Inc | 12.24m | -18.28m | 5.61m | 55.00 | -- | -- | -- | 0.4585 | -1.74 | -1.74 | 1.18 | -1.27 | 2.12 | 1.67 | 8.08 | 222,624.00 | -248.61 | -269.25 | -- | -- | 71.89 | 58.93 | -117.41 | -258.94 | 0.106 | -0.6408 | -- | -- | 25.15 | 97.82 | 23.57 | -- | -- | -- |
| Agape ATP Corp | 1.38m | -2.45m | 6.39m | 21.00 | -- | 1.98 | -- | 4.64 | -0.6396 | -0.6396 | 0.3599 | 0.8366 | 0.4464 | 8.25 | 36.66 | 65,621.91 | -78.78 | -- | -111.56 | -- | 64.23 | -- | -176.47 | -- | 4.66 | -- | 0.0225 | -- | -22.92 | -- | -24.61 | -- | -- | -- |
| Nexalin Technology Inc | 150.16k | -5.40m | 7.20m | 6.00 | -- | 3.82 | -- | 47.94 | -0.7261 | -0.7261 | 0.0202 | 0.1781 | 0.0446 | 0.1679 | 11.53 | 25,026.67 | -160.37 | -- | -202.23 | -- | 82.94 | -- | -3,598.50 | -- | 4.89 | -- | 0.00 | -- | -91.62 | -- | -173.80 | -- | -- | -- |
| Sigyn Therapeutics Inc | 0.00 | -3.70m | 7.27m | 5.00 | -- | -- | -- | -- | -3.08 | -3.08 | 0.00 | -2.91 | 0.00 | -- | -- | 0.00 | -1,085.72 | -493.15 | -- | -- | -- | -- | -- | -10,223.96 | 0.0247 | -2.09 | -- | -- | -- | -- | -41.51 | -- | -- | -- |
| Bioelectronics Corp | 1.61m | -289.82k | 7.41m | 9.00 | -- | -- | -- | 4.60 | -0.00002 | -0.00002 | 0.00007 | -0.0006 | 6.32 | 9.20 | 14.53 | -- | -113.86 | -383.59 | -- | -- | 49.43 | 51.48 | -18.01 | -143.48 | 0.0099 | -0.4909 | -- | -- | 94.01 | -5.09 | 75.01 | -- | -- | -- |
| Neurometrix Inc | 4.38m | -7.94m | 8.49m | 26.00 | -- | 0.4881 | -- | 1.94 | -5.50 | -5.50 | 2.91 | 8.58 | 0.2102 | 1.15 | 8.53 | 168,600.80 | -38.06 | -23.24 | -40.80 | -27.26 | 60.19 | 59.17 | -181.03 | -48.88 | 10.71 | -- | 0.00 | -- | -28.52 | -18.18 | -47.84 | -- | 5.03 | -- |
| ALR Technologies Inc | 9.49k | -8.00m | 9.53m | 6.00 | -- | -- | -- | 1,004.43 | -0.0147 | -0.0147 | 0.00002 | -0.0476 | 0.0358 | -- | -- | 1,581.67 | -3,015.28 | -12,861.64 | -- | -- | 62.49 | -- | -84,283.24 | -406,011.30 | -- | -0.8626 | -- | -- | -- | -- | -42.72 | -- | -- | -- |
Data as of Sep 26 2024. Currency figures normalised to Sigyn Therapeutics Inc's reporting currency: US Dollar USD
0.17%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Brio Capital Management LLCas of 09 Jan 2024 | 2.15k | 0.17% |
Data from 06 Feb 2024 - 06 Feb 2024Source: FactSet Research Systems Inc.
